Arovella Therapeutics Limited (ALA, formerly Suda Pharmaceuticals Ltd) is a biotechnology company focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumours.
Find out what a historical investment in Arovella Therapeutics would be worth today using our ALA stock calculator.
Buying ALA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Arovella Therapeutics in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in ALA
What is the ticker symbol of Arovella Therapeutics?
The ticker symbol for Arovella Therapeutics is ALA.
How much is one share of ALA?
One share of ALA is valued at $0.05 as of 20 November 2026.
What is the market capitalisation of Arovella Therapeutics ALA?
As of 20 November 2026 Arovella Therapeutics has a market cap of $59.23M.
What is the P/E ratio of ALA?
The Price to Earnings ratio of ALA is -8.45.
What is the Earnings Per Share of ALA?
The Earnings Per Share of ALA is -$0.01.
What is the 52-week high for Arovella Therapeutics stock?
The Arovella Therapeutics 52-week high stock price is $0.10.
What is the 52-week low for Arovella Therapeutics stock?
The Arovella Therapeutics 52-week low stock price is $0.05.
Can I buy ALA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ALA shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.